NEW YORK (GenomeWeb News) – Researchers in four European countries will use a €6 million ($7.5 million) grant to develop molecular diagnostic testing technology to accelerate diagnosis of respiratory tract infections, such as pneumonia, the European Commission said yesterday.

The grant will support a collaboration between scientists at the Molecular Diagnostics Research Group at the National University of Ireland, Galway; the French diagnostics firm Genewave; the Finnish biotech company Mobidiag; Assistance Publique Hopitaux de Paris; and University College London.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.